Assessment of Ozonated Sunflower Seed Oil Gel as an Adjunctive Therapy to Mechanical Debridement in the Treatment of Stage II Grade B Periodontitis
Assessment of Ozonated Sunflower Seed Oil Gel as an Adjunctive Therapy to Mechanical Debridement in the Treatment of Stage II Grade B Periodontitis (Clinical and Laboratory Study)
I) Patients:
The present study will be carried on periodontitis patients. The patients will be informed about the treatment steps. This includes the possible effects or risks, and other treatment options according to the rules of the Ethical Committee of Faculty of dentistry, Mansoura University.
Groups:
Group I (negative control): 15 periodontally healthy subjects. Group II (positive control): 15 patients will be treated with mechanical debridement only.
Group III (study group A): 15 patients will be treated with mechanical debridement followed by delivery of sunflower seed oil gel for each pocket. (J MAC BOTANICALS, organic cold pressed helianthus annuus sunflower seed oil, Waterglider LLC. Spokane Valley, WA 99216, USA).
Group IV (study group B): 15 patients will be treated with mechanical debridement followed by delivery of ozonated sunflower seed oil gel for each pocket.( PurO3, Ozonated Sunflower Oil combines organic sunflower oil and ozone, giving you an oxygen-rich, soothing gel with high amounts of ozone, 1220 S Happy Hollow Rd Fayetteville, AR 72701, USA).
Periodontal evaluation will be performed for all patients at baseline and after three months including the following parameters:
- Plaque index (PI).(15)
- Gingival index.(16)
- Probing pocket depth (PPD).(17)
- Clinical attachment level (CAL).(18) B) Gingival crevicular fluid sampling. C) Local drug delivery Adequate amount of prepared ozonated sunflower and sunflower oil gel will be delivered into the selected periodontal pockets.
B) Immunological analysis of TNF-α in GCF
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
I) Patients:
The present study will be carried on periodontitis patients. The patient will be selected from Out Patient Clinic, Department of Oral Medicine, Periodontology, Diagnosis and Oral Radiology, Faculty of Dentistry, Mansoura University. The patients will be informed about the treatment steps. This includes the possible effects or risks, and other treatment options according to the rules of the Ethical Committee of Faculty of dentistry, Mansoura University. The patients must be legally competent to provide written consent before performing any required steps.
A)Inclusion Criteria
- Patients with Stage II Periodontitis grade B periodontitis (horizontal bone loss with maximum probing depth ≤ 5 mm and with 3-4 mm clinical attachment loss).
- Minimum of 20 remaining teeth.
- Age range (25 - 50) years.
- Good compliance with the plaque control instructions following initial therapy.
- Availability for follow up and maintenance program. B) Exclusion Criteria
1. Systemic diseases / drugs which could influence the outcome of the therapy (According to Cornell Medical Index-Health Questionnaire).
2. Receiving periodontal therapy in past 6 month. 3. Pregnant and lactating females. 4. Vulnerable groups of patients (e.g handicapped patients and decisionally impaired individuals).
5. Smoking.
D) Groups:
Group I (negative control): 15 periodontally healthy subjects. Group II (positive control): 15 patients will be treated with mechanical debridement only.
Group III (study group A): 15 patients will be treated with mechanical debridement followed by delivery of sunflower seed oil gel for each pocket. (J MAC BOTANICALS, organic cold pressed helianthus annuus sunflower seed oil, Waterglider LLC. Spokane Valley, WA 99216, USA).
Group IV (study group B): 15 patients will be treated with mechanical debridement followed by delivery of ozonated sunflower seed oil gel for each pocket.( PurO3, Ozonated Sunflower Oil combines organic sunflower oil and ozone, giving you an oxygen-rich, soothing gel with high amounts of ozone, 1220 S Happy Hollow Rd Fayetteville, AR 72701, USA).
II) Clinical Procedures:
- Medical and dental histories will be taken from patients.
- Mechanical debridement will be performed using suitable ultrasonic and hand instruments for positive control and study groups.
A) Periodontal assessment:
Periodontal evaluation will be performed for all patients at baseline and after three months including the following parameters:
- Plaque index (PI).(15)
- Gingival index.(16)
- Probing pocket depth (PPD).(17)
- Clinical attachment level (CAL).(18)
B) Gingival crevicular fluid sampling. The GCF samples will be collected from all subjects at baseline and three months after treatment.(19)
C) Local drug delivery Adequate amount of prepared ozonated sunflower and sunflower oil gel will be delivered into the selected periodontal pockets.
III) Laboratory procedures
A) Pharmaceutics Section: Formulation development:
Sunflower oil and derevatives:
The study will involve using sunflower oil as pure form and/or ozonated using controlled conditions. The oils will be used in preparation of gel formulation for applications in the mouth cavity using different formulation techniques.
- Development of Formulations:
Based on the oil formulation, various gels will be developed with a focus on creating formulations suitable for clinical application.
- Different gel bases will be evaluated to optimize their physicochemical characteristics.
- Physicochemical Parameters of the gel formulations will be assessed to ensure the desired properties.
- The developed gels will undergo in-vitro testing under different conditions.
- Once optimized, the selected gel formulation(s) will be prepared for testing in clinical trials.
B) Immunological analysis of TNF-α in GCF
Assessment of crevicular fluid TNF-α will be performed using enzyme-linked immunosorbent assay technique
Tipo de estudo
Tipo de estudo
Inscrição (Real)
Inscrição
Estágio
Estágio
- Fase inicial 1
Contactos e Locais
Locais de estudo
-
-
-
Al Mansurah, Egito
- Mansoura University, faculty of dentistry
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Patients with Stage II Periodontitis grade B periodontitis (horizontal bone loss with maximum probing depth ≤ 5 mm and with 3-4 mm clinical attachment loss).
- Minimum of 20 remaining teeth.
- Age range (25 - 50) years.
- Good compliance with the plaque control instructions following initial therapy.
- Availability for follow up and maintenance program.
Exclusion Criteria:
- Systemic diseases / drugs which could influence the outcome of the therapy (According to Cornell Medical Index-Health Questionnaire).
- Receiving periodontal therapy in past 6 month.
- Pregnant and lactating females.
- Vulnerable groups of patients (e.g handicapped patients and decisionally impaired individuals).
- Smoking.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Outro: positive control group
control recived mechanical debridment only
|
mechanical debridment
|
|
Sem intervenção: negative control
healthy
|
|
|
Experimental: study group A
sunflower seed oil gel for each pocket
|
patients will be treated with mechanical debridement followed by delivery of sunflower seed oil gel for each pocket
|
|
Experimental: study group B
Ozonated Sunflower Oil
|
patients will be treated with mechanical debridement followed by delivery of ozonated sunflower seed oil gel for each pocket
|
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
assess the clinical effectiveness of the locally delivered ozonated sunflower seed oil as an adjunctive therapy to mechanical debridement in stage II grade B periodontitis
Prazo: 3 month
|
1) Plaque Index: deposits were recorded the level of oral hygiene.The percentage of all tooth surfaces that showed the presence of plaque was determined by recording the full-mouth plaque score dichotomously (presence/absence of plaque) on six different points per tooth.The frequency of positive surfaces was given in percentages relative to the total number of tested surfaces.
2) Gingival index: 0 = Normal gingiva.1=Slight
inflammation.2
= Moderate glazing.
3 = Severe.
3) Probing pocket depth:For each group, the PPD was measured from the base of the pocket on the whole mouth to the free gingival margin.4)
Clinical attachment level:It is the space between the base of the periodontal pocket and CEJ.
Six locations were used to measure the clinical attachment loss: three on the facial surface and three on the lingual or palatal surface.5)
Bleeding on probing:take the percentage from all teeth that appear BOP
|
3 month
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
assess the impact of the locally delivered ozonated sunflower seed oil as an adjunctive therapy to mechanical debridement on the GCF level of TNF-α in stage II periodontitis
Prazo: 3 months
|
GCF sample will be assessed for TNF-α.
TNF-α. is an inflammatory mediator.
Assessment of gingival crevicular fluid(GCF) TNF-α will be performed using enzyme-linked immunosorbent assay technique.
|
3 months
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Ahmed Hashem Alshareef, Bachelors degree, Mansoura University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Início do estudo
Conclusão Primária (Real)
Conclusão Primária
Conclusão do estudo (Real)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- M04020250M
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .